Dezocine (CAS 53648-55-8): Properties, Uses, and Supplier Information

Dezocine is an atypical opioid ***gesic used for the treatment of moderate to severe pain. It is administered via intravenous infusion or intramuscular injection. Dezocine acts as a partial agonist of the μ- and κ-opioid receptors, providing ***gesia and euphoria without the dysphoria or hallucinations associated with other κ-opioid receptor agonists.

Frequently Asked Questions about Dezocine

Q: What is the primary use of Dezocine?

A: Dezocine is primarily used for the management of moderate to severe pain, particularly in postoperative settings.

Q: How is Dezocine administered?

A: Dezocine is administered through intravenous infusion or intramuscular injection.

Q: Is Dezocine currently available in the United States?

A: No, Dezocine was discontinued in the United States in 2011. However, it is still widely used in China for postoperative pain management.

Q: What makes Dezocine unique among opioids?

A: Dezocine is unusual among opioids as it is one of the only primary amines known to be active as an opioid. It also has a unique receptor profile, acting as a partial agonist at μ- and κ-opioid receptors without producing the dysphoria or hallucinations associated with other κ-opioid receptor agonists.